Biotie Therapies Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 42

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

  • Investments
  • 2

Biotie Therapies General Information

Description

Provider of drug development services designed for neurodegenerative and psychiatric disorders. The company's drug development services primarily focus on developing and selling therapeutics for central nervous system disorders, enabling medical institutes to treat and reduce alcohol consumption, Parkinson's disease, and other conditions.

Contact Information

Website
www.biotie.com
Formerly Known As
Biotie Therapies Corp.
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Joukahaisenkatu 6
  • 20520 Turku
  • Finland
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Joukahaisenkatu 6
  • 20520 Turku
  • Finland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotie Therapies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biotie Therapies‘s full profile, request access.

Request a free trial

Biotie Therapies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of drug development services designed for neurodegenerative and psychiatric disorders. The company's drug devel
Drug Discovery
Turku, Finland
42 As of 2016

Raritan, NJ
 

Seoul, South Korea
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biotie Therapies Competitors (75)

One of Biotie Therapies’s 75 competitors is Johnson&Johnson Innovative Medicine, a Venture Capital-Backed company based in Raritan, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Johnson&Johnson Innovative Medicine Venture Capital-Backed Raritan, NJ
Dong-A ST Co Corporation Seoul, South Korea
Sanofi Pasteur Corporation Paris, France
Astrogen Venture Capital-Backed Daegu, South Korea
Neurelis Venture Capital-Backed San Diego, CA
You’re viewing 5 of 75 competitors. Get the full list »

Biotie Therapies Patents

Biotie Therapies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019405950-A1 Methods for treating cancer using tozadenant Inactive 20-Dec-2018
CA-3123856-A1 Methods for treating cancer using tozadenant Inactive 20-Dec-2018
EP-3897653-A1 Methods for treating cancer using tozadenant Inactive 20-Dec-2018
US-20220088024-A1 Methods for treating cancer using tozadenant Inactive 20-Dec-2018
AU-2017337053-A1 Compositions and methods for treating alzheimer's disease and parkinson's disease Active 30-Sep-2016 A61K31/17
To view Biotie Therapies’s complete patent history, request access »

Biotie Therapies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biotie Therapies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biotie Therapies‘s full profile, request access.

Request a free trial

Biotie Therapies Acquisitions (2)

Biotie Therapies’s most recent deal was a Merger/Acquisition with Synosia Therapeutics for . The deal was made on 01-Feb-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Synosia Therapeutics 01-Feb-2011 Merger/Acquisition Drug Discovery
Elbion 14-Nov-2008 Merger/Acquisition Drug Delivery
To view Biotie Therapies’s complete acquisitions history, request access »

Biotie Therapies FAQs

  • When was Biotie Therapies founded?

    Biotie Therapies was founded in 1998.

  • Where is Biotie Therapies headquartered?

    Biotie Therapies is headquartered in Turku, Finland.

  • What is the size of Biotie Therapies?

    Biotie Therapies has 42 total employees.

  • What industry is Biotie Therapies in?

    Biotie Therapies’s primary industry is Drug Discovery.

  • Is Biotie Therapies a private or public company?

    Biotie Therapies is a Private company.

  • What is the current valuation of Biotie Therapies?

    The current valuation of Biotie Therapies is .

  • What is Biotie Therapies’s current revenue?

    The current revenue for Biotie Therapies is .

  • How much funding has Biotie Therapies raised over time?

    Biotie Therapies has raised $79.2M.

  • Who are Biotie Therapies’s investors?

    5AM Ventures, Aboa Venture Management, Alpine Investors, Aravis, and Burrill & Co are 5 of 20 investors who have invested in Biotie Therapies.

  • Who are Biotie Therapies’s competitors?

    Johnson&Johnson Innovative Medicine, Dong-A ST Co, Sanofi Pasteur, Astrogen, and Neurelis are some of the 75 competitors of Biotie Therapies.

  • When was Biotie Therapies acquired?

    Biotie Therapies was acquired on 18-Apr-2016.

  • Who acquired Biotie Therapies?

    Biotie Therapies was acquired by Acorda Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process